Association of obesity and cardiovascular disease and progress in pharmacotherapy: what is next for obesity?

Mallah, Manthar Ali; Soomro, Tahmina; Noreen, Sobia; Ali, Mukhtiar; Kafle, Akriti; Khatoon, Nafeesa; Naveed, Muhammad

Mallah, Manthar Ali; Soomro, Tahmina; Noreen, Sobia; Ali, Mukhtiar; Kafle, Akriti; Khatoon, Nafeesa; Naveed, Muhammad.

Affiliation

Mallah MA; College of Public Health, Zhengzhou University, Zhengzhou, China.
Soomro T; Department of Sociology, Shah Abdul Latif University, Khairpur.
Noreen S; Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur.
Ali M; Department of Chemical Engineering, Quaid-e-Awam University of Engineering, Science and Technology, Nawabshah, Sindh, Pakistan.
Kafle A; Nursing School, College of Public Health, Zhengzhou University, Zhengzhou.
Khatoon N; College of Public Health, Zhengzhou University, Zhengzhou, China.
Naveed M; Department of Clinical Pharmacy, School of Pharmacy, Nanjing Medical University, Nanjing, China.

Int J Rehabil Res ; 46(1): 14-25, 2023 03 01.

Article in En | MEDLINE | ID: mdl-36727942

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Heart Failure / Hypertension Type of study: Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: Int J Rehabil Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google